Balanced transfusion therapy in patients with life-threatening haemorrhage;Rationel blodkomponentterapi ved livstruende blødninger

Ugeskrift for Laeger

Volumn 167, Issue 25-31, 2005, Pages 2753-2755

  Johansson, Pär Ingemar ^a   Lethagen, Stefan ^a   Lippert, Freddy ^a   Stensballe, Jakob ^a   Arlien Søborg, Peter ^b   Alsbjørn, Bjarne ^b   Callesen, Torben ^b   Dziegiel, Morten ^b   Eskesen, Vagn ^b   Espersen, Kurt ^b   Grønborg, Henrik ^b   Hyllested, Mette ^b   Jacobsen, Niels ^b   Langhoff Roos, Jens ^b   Larsen, Bo ^b   Nielsen, Lars Bo ^b   Pedersen, Carsten Boe ^b   Rasmussen, Allan ^b   Rosenberg, Iben ^b   Schroeder, Torben V ^b   Steinbruchel, Daniel ^b   Thomsen, Annemarie B ^b   Thorsen, Sixtus ^b   Welling, Karen Lise ^b   more..

^a Rigshospitalet   (Denmark)

^b Blodbank ^*

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ALGORITHM; BLEEDING; BLOOD BANK; BLOOD TRANSFUSION; DENMARK; EMERGENCY TREATMENT; ERYTHROCYTE; LETHALITY; PATIENT MONITORING; PRACTICE GUIDELINE; SHORT SURVEY; STANDARDIZATION; THROMBOCYTE; UNIVERSITY HOSPITAL;

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT TRANSFUSION; DENMARK; HEMORRHAGE; HUMANS; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 21444453091     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (10)

1. Johansson P, Sørensen H. Transfusion practice in massively bleeding patients, time for a change? Vox Sang 2005 (i trykken).
2. Hardy JF, De Moerloose P, Samama M. Transfusion massive etcoagulopathie: physiopathologie et implications cliniques. Can J Anaesth 2004;51:293-310.
3. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001;29:1261-7.
4. Sundhedsstyrelsen. Vejledning om behandling med blod, blodkomponenter og visse blodderivater samt forholdsregler mod komplikationer herved. http://www.sst.dk/publ/vejledninger/98/beh_blod/vejled.html/november 2004
5. Practice Guidelines for blood component therapy; a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996;84:732-47.
6. Stainsby D, MacLennan S, Hamilton PJ. Management of massive blood loss: a template guideline. Br J Anaesth 2000;85:487-91.
7. Ceccherini-Nelli L, Filipponi F, Mosca F et al. The risk of contracting an infectious disease from blood transfusion. Transplant Proc 2004;36:680-2.
8. Dickmeiss E, Christiansen AH, Smith E. Risiko for smitte med donorblod i Danmark ved årtusindskiftet. Ugeskr Læger 2001;163:2628-32.
9. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2004; http://bja.oupjournals. org/cgi/content/abstract/aeh290v1/november 2004
10. Vamvakas EC. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003;43:963-73.